Idéal Investisseur
Français English
CAC 40 : Market open
8 191,10 pts
+0.41%


Last updated : 27/04/2026 - 12h14
🏠 Home   ➤    Stock news

EssilorLuxottica Shares Surge by +11.68% and Cross the 300 Euros Mark

EssilorLuxottica's stock price soared by 11.68% at the opening this morning, reaching 308.90 euros, marking a new historical record by surpassing the 300 euros threshold for the first time. This increase comes in contrast to the CAC 40, which fell by 0.8%, demonstrating a performance significantly uncorrelated with the Paris market.


EssilorLuxottica Shares Surge by +11.68% and Cross the 300 Euros Mark

Record Performance Following Quarterly Results

EssilorLuxottica's stock exhibited an 11.68% increase at this morning's opening, bringing its price to 308.90 euros. This rise occurs as the CAC 40 declines by 0.8%, showcasing a performance significantly detached from the Parisian market. The stock has crossed the 300 euros mark for the first time, setting a new all-time high. Over the past seven days, the cumulative increase reached 11.12%, while the quarterly performance stands at 27.17%. Over the past year, the stock of the Franco-Italian optical giant has surged by 43.34%, significantly outperforming the Paris index, which recorded an 8.42% increase over the same period. This stock market rally follows the announcement of the third-quarter 2025 results, released last Thursday after the market closed. The group reported a revenue of 6.867 billion euros for the quarter, up 11.7% at constant exchange rates, exceeding analysts' expectations who had estimated around 6.75 billion euros. The management described this performance as the best quarter since the group's inception in 2018. The Ray-Ban Meta glasses equipped with artificial intelligence features reportedly contributed more than 4 percentage points to this quarterly growth. The day before this announcement, on October 15, the group also announced the acquisition of RetinAI, a company specializing in artificial intelligence applied to ocular health solutions. Following these announcements, several analysts have raised their price targets, some up to 350 euros.

Technical Analysis Highlights Strong Uptrend

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Technically, the stock is now significantly above its former resistance level set at 295.80 euros, which now serves as a potential support in case of a pullback. The price is also well above its 50-day and 200-day moving averages, located at 268.52 and 258.97 euros respectively, indicating a well-established structural bullish trend. The Relative Strength Index (RSI) is at 57, in a mid-range that indicates neither overbought nor oversold conditions. The beta coefficient, measured at 0.06, shows a very low sensitivity to variations in the CAC 40, partly explaining the stock's autonomous performance despite the Paris market's decline this morning. The Bollinger Bands, currently framing the price between 267.40 and 282.32 euros, are significantly exceeded on the upside, indicating an expansion of volatility which remains, however, contained at 5.60% over a month. The traded volume represents 0.09% of the capital, a moderate level that could increase during the session. The Chaikin Money Flow, slightly positive at 0.01, suggests a balance between buying and selling flows, while the MACD indicator shows a signal line above the MACD line, with a negative histogram at -0.85, indicating a dynamic that could weaken in the short term despite the strong rise observed this morning.



Sector Luxe Fournitures Médicales


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 28 491 millions d'euros
  • Revenue growth: 11,2 %
  • EBITDA: 6 492 millions d'euros
  • EBITDA margin: 22,8 %
  • Net income: 2 443 millions d'euros
  • Free cash flow: 2 796 millions d'euros
  • Net debt: 10 853 millions d'euros
  • Dividend per share: 4,00 euros
Guidance from the release
  • C’est une année historique pour EssilorLuxottica : pour la première fois depuis l’origine du Groupe, notre chiffre d’affaires a enregistré une croissance à deux chiffres à taux de change constant, après un quatrième trimestre affichant une croissance record de 18,4 %.
  • Résultats annuels 2025 marquent une croissance du chiffre d’affaires de 11,2% et une marge opérationnelle ajustée de 15,7%; le cash-flow libre atteint 2,8 milliards d'euros; dividende proposé de 4,00 euros; acquisitions et initiatives med-tech renforcent le positionnement.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit